Former President Joe Biden sent a statement on social media after learning of his “aggressive” prostate cancer diagnosis.
Yesterday (May 18), the personal office for the 46th president of the United States shared the following statement: “Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms.
“On Friday he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone.”
The Gleason score, which compares the appearance of malignant cells to normal cells on a scale of 1 to 10, is assigned to prostate tumors. A malignancy with a score of nine is considered to be one of the most “aggressive.”
The statement continued: “While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive, which allows for effective management.
“The President and his family are reviewing treatment options with his physicians.”
In a Twitter post, the 82-year-old shared a picture of himself, his wife, Jill, and their cat.
The caption said: “Cancer touches us all. Like so many of you, Jill and I have learned that we are strongest in the broken places.
“Thank you for lifting us up with love and support.”
Following the announcement of his predecessor’s sickness, President Donald Trump responded on Truth Social.
He posted: “Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis. We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery.”
Biden was previously been diagnosed with cancer; prior to taking office, he had several non-melanoma skin cancers surgically removed, and in February 2023, he also had a malignant tumor removed from his chest.
He underwent surgery in November 2021 to remove a benign but possibly precancerous growth from his colon.
Prostate cancer is the second most common cause of cancer-related deaths in men, after lung cancer, and approximately one in eight men will receive a prostate cancer diagnosis in their lifetime, according to the American Cancer Society.
Although the majority of males who are diagnosed do not pass away from the condition, it kills about one in 44 of them.